• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY CMW - 9610921 DEPUY/CMW 2G; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY CMW - 9610921 DEPUY/CMW 2G; BONE CEMENT : BONE CEMENT Back to Search Results
Model Number 5450-32-500
Device Problem Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problems Edema (1820); Muscular Rigidity (1968); Pain (1994); No Code Available (3191)
Event Date 01/19/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
The patient presented for post-primary evaluations of the left knee on (b)(6) 2018 and (b)(6) 2018.The patient complained of pain, "snapping, cracking, and popping" of the knee, swelling, and stiffness.X-ray images showed the components to be intact, aligned, and with no fractures.The physician indicated he suspected tibial tray loosening.There is no evidence of revision or intervention.Three depuy cement products were used during the primary operation.Doi: (b)(6) 2016; doe: (b)(6) 2018; left knee.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : update 24-feb-2021: the investigation was re-opened upon receipt of additional information.No device associated with this report was received for examination.Visual examination of the provided photographs confirmed the reported event.Based on previous investigations, this complication of joint replacement is unlikely to have been the result of a device failing to meet required specifications.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Device history lot : device history reviewed on (date) 1 unrelated non-conformances on this lot number.Final micro and sterility tests passed.(b)(4) units released.Lot expiry date: 31 mar 19.There were no anomalies identified on this lot.Dmf# - 13704 , trade name ¿ gentamicin sulphate , active ingredient(s) ¿ gentamicin sulphate , dosage form - powder , strength ¿ 1.0g active in our cements.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DEPUY/CMW 2G
Type of Device
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY CMW - 9610921
cornford rd
blackpool FY4 4 QQ
UK  FY4 4QQ
MDR Report Key9830224
MDR Text Key188219961
Report Number1818910-2020-07808
Device Sequence Number1
Product Code MBB
UDI-Device Identifier10603295174271
UDI-Public10603295174271
Combination Product (y/n)N
PMA/PMN Number
K081163
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup
Report Date 10/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2019
Device Model Number5450-32-500
Device Catalogue Number545032500
Device Lot Number8283423
Was Device Available for Evaluation? No
Date Manufacturer Received02/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATTUNE MEDIAL DOME PAT 35MM; ATTUNE PS FEM LT SZ 6 NAR CEM; ATTUNE PS RP INSRT SZ 6 7MM; ATTUNE RP TIB BASE SZ 4 CEM; DEPUY/CMW 2G; DEPUY/CMW 2G; DEPUY/CMW 2G
Patient Outcome(s) Required Intervention;
Patient Age50 YR
-
-